CervoMed Inc. Proceeds from Related Party Debt
CervoMed Inc. (CRVO) reported Proceeds from Related Party Debt of $400.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2016-03-25
- CervoMed Inc. proceeds from related party debt for the quarter ending 2014-12-31 was $0.00.
- CervoMed Inc. proceeds from related party debt for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. proceeds from related party debt for the quarter ending 2013-09-30 was $450.00K.
- CervoMed Inc. proceeds from related party debt for fiscal 2014 was $400.00K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $0.00 derived: sum of 2 quarters · filed 2016-03-25 | $400.00K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $400.00K 10-Q · filed 2014-11-12 | ||
| 2014-06-30 | $400.00K 10-Q · filed 2014-08-14 | |||
| 2013-09-30 | $450.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $650.00K 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $200.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |